Samalin Investment Counsel’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,292
Closed -$26.4K 293
2023
Q1
$26.4K Buy
5,292
+417
+9% +$2.64K 0.02% 259
2022
Q4
$23.5K Sell
4,875
-8,708
-64% -$42.8K 0.01% 248
2022
Q3
$139K Buy
13,583
+1,666
+14% +$23.2K 0.1% 207
2022
Q2
$166K Buy
11,917
+1,584
+15% +$25.2K 0.12% 206
2022
Q1
$175K Buy
10,333
+2,833
+38% +$48.8K 0.11% 226
2021
Q4
$185K Buy
+7,500
New +$237K 0.11% 230
2021
Q2
Sell
-2,333
Closed -$69K 246
2021
Q1
$69K Hold
2,333
0.05% 230
2020
Q4
$60K Sell
2,333
-1,459
-38% -$29.3K 0.05% 220
2020
Q3
$55K Buy
3,792
+834
+28% +$13.8K 0.05% 195
2020
Q2
$61K Buy
2,958
+625
+27% +$16.5K 0.06% 166
2020
Q1
$73K Sell
2,333
-5,006
-68% -$126K 0.1% 140
2019
Q4
$118K Buy
+7,339
New +$106K 0.1% 207

Other funds holding VSTM

Samalin Investment Counsel's VSTM Position: Q2 2023 in Review

Samalin Investment Counsel sold out of Verastem (VSTM) in Q2 2023, closing a stake of 5,292 shares — an estimated $26.4K sold.

Samalin Investment Counsel first reported a position in VSTM in Q4 2019 and held it in 12 quarters. The position peaked at $185K in Q4 2021. 61 funds tracked by Wall St. Rank hold VSTM as of Q2 2023.

  • Samalin Investment Counsel reported no remaining Verastem position as of Q2 2023 after selling out during the quarter.
  • Samalin Investment Counsel sold 5,292 Verastem shares in Q2 2023, an estimated $26.4K.
  • Samalin Investment Counsel first reported a position in Verastem in Q4 2019 and held it in 12 quarters.
  • Samalin Investment Counsel's Verastem position peaked at $185K in Q4 2021.
  • 61 funds tracked by Wall St. Rank held Verastem as of Q2 2023.

Based on Samalin Investment Counsel's 13F filing for Q2 2023, filed 3 Aug 2023.